Our team of experts brings you cancer-related news and research updates.
The American Cancer Society Mission Boost grant helps rescue science that sometimes falls into the valley of death, where promising research comes to an abrupt end because it otherwise can’t get the funding it needs to cross the bridge between discovery and helping patients. Read about 4 of the cancer researchers who are using Mission Boost grants today.
Tom Bajoras says he’s written some of his best music during nights when pain kept him from sleeping. Bajoras has been playing and writing music since he was a child, and he’s found the creative process helpful during treatment for a pancreatic neuroendocrine tumor (NET).
Researchers at the American Cancer Society found that 6 cancers proven to be related to obesity are increasing more rapidly in people younger than 50 than those older than 50. To understand what this study means to you and your loved ones, read these 5 key takeaway messages.
When John Christman’s doctors diagnosed him with pancreatic cancer in 1989, he was what he calls “just a regular guy.” Today Christman is 62, recently retired, and looking forward to a long, fun life with his grandchildren.
The US Food and Drug Administration (FDA) has approved Lutathera (lutetium Lu 177 dotatate) to treat people with gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Pancreatic cancer survivor Kellie Williams, 40, says fate brought her to Zumbrota, Minnesota, just 25 miles from Mayo Clinic, a year before her diagnosis.
Pancreatic cancer death rates for whites and blacks in the United States are going in two different directions. Rates among whites have been climbing since the late 1990s. The rates for blacks have been falling since peaking in 1989, according to an American Cancer Society analysis published November 7 in the Journal of the National Cancer Institute.
Pancreatic cancer is one of the hardest cancers to find and treat. But, researchers are working hard to figure out new ways to tackle the disease.